Robert H. Vonderheide, MD, DPhil
October 29, 2024
Robert H. Vonderheide, MD, DPhil, is the Director of the Abramson Cancer Center of the University of Pennsylvania and the John H. Glick, MD, Abramson Cancer Center’s Director Professor in […]
Katherine L. Nathanson, MD
October 29, 2024
Raina M Merchant, MD, MSHP, FAHA
October 29, 2024
Dr. Merchant is a tenured Professor of Emergency Medicine at the University of Pennsylvania and has secondary appointments in the Department of Internal Medicine, Department of Anesthesia and Critical Care, […]
Qi Long, PhD
September 9, 2024
Dr. Long’s research purposefully includes novel statistical and machine learning research and impactful biomedical research, each of which reinforces the other. Its thrust is to develop statistical and machine learning […]
Carmen E. Guerra, MD, MSCE, FACP
September 9, 2024
Vice Chair of Diversity and Inclusion, Department of Medicine Associate Director of Diversity and Outreach, Abramson Cancer Center Advisory Dean, Dr. Helen O. Dickens House, Perelman School of Medicine Ruth […]
Richard Aplenc, MD, PhD, MSCE
September 9, 2024
Dr. Aplenc is a Professor of Pediatrics in the Department of Pediatrics with a secondary appointment in the Department of Biostatistics, Epidemiology and Informatics. His research focus is in pediatric […]
Announcement
September 2022: The new Biomedical Data Science Seminar Series is launched
September 9, 2023
Our Center for Cancer Data Science (CCDS) is co-sponsoring the new Biomedical Data Science Seminar Series launched in September, 2022, with the Center For AI and Data Science for Integrated […]
Award
The Pre-medical Cancer Immunotherapy Network for Canine Trials (PRECINCT) renewed for another five years
June 26, 2023
Qi Long, PhD and Nicola Mason, B.Vet.Med, PhD received a new five year U24 grant from NIH/NCI to continue leading the Coordinating Center for the Pre-medical Cancer Immunotherapy Network for […]
Award
Team Penn won the Honorable Mention in the NIH Long COVID Computational Challenge (L3C)
June 26, 2023
Dr. Qi Long’s lab in the CCDS partnered with Dr. Mayur Naik’s lab in Computer and Information Science to form a team, Team Penn, to participate in the NIH Long […]
Award
New NCI U01 on developing responsible AI tools to address data bias and disparities in cancer research
June 26, 2023
Dr. Qi Long received a new U01 grant from NCI, entitled “Robust Privacy Preserving Distributed Analysis Platform for Cancer Research: Addressing Data Bias and Disparities.” This grant enables Dr. Long’s group […]
Publication
New in JNCI: Pandemic not associated with treatment initiation delays for patients with advanced cancer
January 12, 2022
Rebecca Hubbard, PhD, co-led a new JNCI paper that studied >14k patients with advanced cancer in a national EHR database to show that time from diagnosis to treatment and choice of therapy […]
Publication
New in PNAS: Minority collapse in deep learning, unfairness for minority groups in high-stakes decisionmaking
November 17, 2021
Our recent PNAS paper introduced the Layer-Peeled Model in deep learning that can: 1) predict a hitherto unknown phenomenon termed “Minority Collapse” in imbalanced training; and 2) explain neural collapse […]
Publication
New at NeurIPS 2021: Assessing Fairness in the Presence of Missing Data
November 17, 2021
Our new paper “Assessing Fairness in the Presence of Missing Data” has been accepted for publication at NeurIPS 2021, a leading machine learning /artificial intelligence conference. Learn More
Publication
New in JAMA: Some Cancer Patients More Likely to Receive Immunotherapy, Despite Lack of Benefits
November 12, 2021
Rebecca Hubbard, PhD, and Qi Long, PhD, are co-authors on this new JAMA Oncology paper that finds solid-tumor cancer patients ineligible for clinical trials receive immunotherapy at greater rates — […]